Briefly

Venus Medtech buys Israeli heart valve firm

Chinese heart disease treatment company Venus Medtech has acquired Israeli company Cardiovalve for $300 million, both companies said in a joint statement. Headquartered in Hangzhou, Zhejiang province, Venus Medtech is a leader in transcatheter heart valvular therapies in China. Cardiovalve developed a technology to replace heart valves without the need for open-heart surgery and using only catheterization.

New yuan loans at 1.27 trillion yuan last month

China's new yuan-denominated loans totaled 1.27 trillion yuan ($200 billion) last month, down 160.5 billion yuan from the same period last year, central bank data showed. The M2, a broad measure of money supply that covers cash in circulation and all deposits, increased 8.5 percent year-on-year to 235.6 trillion yuan at the end of November.

Xinhua